Search
Now showing items 1-2 of 2
Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer
(BioMed Central (BMC), http://www.infectagentscancer.com/, 2014-08)
Background: The worldwide administration of bivalent and quadrivalent HPV vaccines has resulted in cross-protection against non-vaccine HPV types. Infection with multiple HPV types may offer similar cross-protection in the ...
Impact of human immunodeficiency virus infection on survival and acute toxicities from chemoradiation therapy for cervical cancer patients in a limited-resource setting
(Elsevier, https://www.elsevier.com/en-xm, 2018-05-01)
Purpose—To prospectively compare survival between human immunodeficiency virus (HIV)-infected versus HIV-uninfected cervical cancer patients who initiated curative chemoradiation therapy (CRT) in a limited-resource ...